236 related articles for article (PubMed ID: 8810265)
1. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
[TBL] [Abstract][Full Text] [Related]
2. Point mutations affecting the oligomeric structure of Nm23-H1 abrogates its inhibitory activity on colonization and invasion of prostate cancer cells.
Kim YI; Park S; Jeoung DI; Lee H
Biochem Biophys Res Commun; 2003 Jul; 307(2):281-9. PubMed ID: 12859952
[TBL] [Abstract][Full Text] [Related]
3. Site-directed mutation of Nm23-H1. Mutations lacking motility suppressive capacity upon transfection are deficient in histidine-dependent protein phosphotransferase pathways in vitro.
Freije JM; Blay P; MacDonald NJ; Manrow RE; Steeg PS
J Biol Chem; 1997 Feb; 272(9):5525-32. PubMed ID: 9038158
[TBL] [Abstract][Full Text] [Related]
4. Nm23-H1 metastasis suppressor phosphorylation of kinase suppressor of Ras via a histidine protein kinase pathway.
Hartsough MT; Morrison DK; Salerno M; Palmieri D; Ouatas T; Mair M; Patrick J; Steeg PS
J Biol Chem; 2002 Aug; 277(35):32389-99. PubMed ID: 12105213
[TBL] [Abstract][Full Text] [Related]
5. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
[TBL] [Abstract][Full Text] [Related]
6. A novel function for the nm23-H1 gene: overexpression in human breast carcinoma cells leads to the formation of basement membrane and growth arrest.
Howlett AR; Petersen OW; Steeg PS; Bissell MJ
J Natl Cancer Inst; 1994 Dec; 86(24):1838-44. PubMed ID: 7990158
[TBL] [Abstract][Full Text] [Related]
7. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
[TBL] [Abstract][Full Text] [Related]
8. Nm23 and tumour metastasis: basic and translational advances.
Freije JM; MacDonald NJ; Steeg PS
Biochem Soc Symp; 1998; 63():261-71. PubMed ID: 9513729
[TBL] [Abstract][Full Text] [Related]
9. Double mutant P96S/S120G of Nm23-H1 abrogates its NDPK activity and motility-suppressive ability.
Zhou Q; Yang X; Zhu D; Ma L; Zhu W; Sun Z; Yang Q
Biochem Biophys Res Commun; 2007 May; 356(2):348-53. PubMed ID: 17335772
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity of nm23-H1 on invasion and colonization of human prostate carcinoma cells is not mediated by its NDP kinase activity.
Lee HY; Lee H
Cancer Lett; 1999 Oct; 145(1-2):93-9. PubMed ID: 10530775
[TBL] [Abstract][Full Text] [Related]
11. Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis.
Negroni A; Venturelli D; Tanno B; Amendola R; Ransac S; Cesi V; Calabretta B; Raschellà G
Cell Death Differ; 2000 Sep; 7(9):843-50. PubMed ID: 11042679
[TBL] [Abstract][Full Text] [Related]
12. nm23-H1 suppresses invasion of oral squamous cell carcinoma-derived cell lines without modifying matrix metalloproteinase-2 and matrix metalloproteinase-9 expression.
Khan MH; Yasuda M; Higashino F; Haque S; Kohgo T; Nakamura M; Shindoh M
Am J Pathol; 2001 May; 158(5):1785-91. PubMed ID: 11337376
[TBL] [Abstract][Full Text] [Related]
13. Wild-type NM23-H1, but not its S120 mutants, suppresses desensitization of muscarinic potassium current.
Otero AS; Doyle MB; Hartsough MT; Steeg PS
Biochim Biophys Acta; 1999 Mar; 1449(2):157-68. PubMed ID: 10082974
[TBL] [Abstract][Full Text] [Related]
14. Transfection of human nm23-H1 into the human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity.
Leone A; Flatow U; VanHoutte K; Steeg PS
Oncogene; 1993 Sep; 8(9):2325-33. PubMed ID: 8395676
[TBL] [Abstract][Full Text] [Related]
15. MMTV-associated transcription factor binding sites increase nm23-H1 metastasis suppressor gene expression in human breast carcinoma cell lines.
Ouatas T; Clare SE; Hartsough MT; De La Rosa A; Steeg PS
Clin Exp Metastasis; 2002; 19(1):35-42. PubMed ID: 11918081
[TBL] [Abstract][Full Text] [Related]
16. Elevation of breast carcinoma Nm23-H1 metastasis suppressor gene expression and reduced motility by DNA methylation inhibition.
Hartsough MT; Clare SE; Mair M; Elkahloun AG; Sgroi D; Osborne CK; Clark G; Steeg PS
Cancer Res; 2001 Mar; 61(5):2320-7. PubMed ID: 11280805
[TBL] [Abstract][Full Text] [Related]
17. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
[TBL] [Abstract][Full Text] [Related]
18. Two-component kinase-like activity of nm23 correlates with its motility-suppressing activity.
Wagner PD; Steeg PS; Vu ND
Proc Natl Acad Sci U S A; 1997 Aug; 94(17):9000-5. PubMed ID: 9256424
[TBL] [Abstract][Full Text] [Related]
19. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity.
Zhang Q; McCorkle JR; Novak M; Yang M; Kaetzel DM
Int J Cancer; 2011 Jan; 128(1):40-50. PubMed ID: 20209495
[TBL] [Abstract][Full Text] [Related]
20. Increased sensitivity to cisplatin by nm23-transfected tumor cell lines.
Ferguson AW; Flatow U; MacDonald NJ; Larminat F; Bohr VA; Steeg PS
Cancer Res; 1996 Jul; 56(13):2931-5. PubMed ID: 8674043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
